Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heping Hu

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|January 14, 2017
A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6Pei Min, Wenshuai Li, Deqing Zeng, et al.
Molecular Biomedicine|May 22, 2026
RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axisXiaomeng Yao, Yunkai Lin, Pingping Chen, et al.
Nature Communications|December 20, 2014
Mutational landscape of intrahepatic cholangiocarcinomaShanshan Zou, Jiarui Li, Huabang Zhou, et al.
Frontiers in Pharmacology|January 26, 2026
Berberine suppresses hepatocellular carcinoma progression by blocking IL-4-JAK1-STAT6-mediated M2 polarization of macrophagePeng Wang, Yuwen Zhong, Mengkai Li, et al.
Hepatology (Baltimore, Md.)|January 7, 2017
Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patientsDaimin Xiang, Zhuo Cheng, Hui Liu, et al.
Molecular Genetics and Metabolism|May 5, 2016
New observation of sialuria prompts detection of liver tumor in previously reported patientNeena L Champaigne, Jules G Leroy, Priya S Kishnani, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Medicine|November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitisHong Ma, Minde Zeng, Ying Han, et al.
Oncotarget|March 31, 2016
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statementShuqun Cheng, Jiamei Yang, Feng Shen, et al.
Liver Cancer|January 2, 2023
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Yang, Juxian Sun, Mengchao Wu, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|January 14, 2017
A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6Pei Min, Wenshuai Li, Deqing Zeng, et al.
Molecular Biomedicine|May 22, 2026
RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axisXiaomeng Yao, Yunkai Lin, Pingping Chen, et al.
Nature Communications|December 20, 2014
Mutational landscape of intrahepatic cholangiocarcinomaShanshan Zou, Jiarui Li, Huabang Zhou, et al.
Frontiers in Pharmacology|January 26, 2026
Berberine suppresses hepatocellular carcinoma progression by blocking IL-4-JAK1-STAT6-mediated M2 polarization of macrophagePeng Wang, Yuwen Zhong, Mengkai Li, et al.
Hepatology (Baltimore, Md.)|January 7, 2017
Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patientsDaimin Xiang, Zhuo Cheng, Hui Liu, et al.
Molecular Genetics and Metabolism|May 5, 2016
New observation of sialuria prompts detection of liver tumor in previously reported patientNeena L Champaigne, Jules G Leroy, Priya S Kishnani, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Medicine|November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitisHong Ma, Minde Zeng, Ying Han, et al.
Oncotarget|March 31, 2016
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statementShuqun Cheng, Jiamei Yang, Feng Shen, et al.
Liver Cancer|January 2, 2023
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)Yu Yang, Juxian Sun, Mengchao Wu, et al.
Pageof 5